Study of AHB-171 in Chronic Hepatitis B Participants

Clinical trial NCT07630727 · RECRUITING

Trial details

NCT number: NCT07630727
Sponsor: Ausper Biopharma Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis B, Chronic (CHB)

Start date: 2026-06-24
Primary completion: 2029-03-31
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.